Hoxton Financial, Inc. - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Hoxton Financial, Inc. ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$0422
-48.7%
0.00%
Q4 2015$08220.0%0.00%
Q3 2015$08220.0%0.00%
Q2 2015$0822
+105.5%
0.00%
Q1 2015$04000.0%0.00%
Q4 2014$04000.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Northeast Financial Consultants Inc 150,000$54,0000.03%
HUDSON VALLEY INVESTMENT ADVISORS INC /ADV 200,000$73,0000.02%
Benin Management CORP 83,000$30,0000.02%
TWO SIGMA SECURITIES, LLC 36,129$13,0000.02%
NIXON PEABODY TRUST CO 10,000$4,0000.00%
Advisory Services Network, LLC 23,000$8,0000.00%
Sheaff Brock Investment Advisors, LLC 69,500$25,0000.00%
First Heartland Consultants, Inc. 21,500$8,0000.00%
INVESTMENT CENTERS OF AMERICA INC 10,000$4,0000.00%
Renaissance Technologies 1,266,400$460,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders